Pharvaris N.V. Files Routine 6-K Report

TL;DR

Pharvaris N.V. filed a routine 6-K, no major news.

AI Summary

Pharvaris N.V. filed a Form 6-K on November 12, 2025, reporting for the month of November 2025. The company, previously known as Pharvaris, B.V., is a foreign private issuer based in Leiden, The Netherlands, and is required to file annual reports under Form 20-F. The filing does not contain specific financial figures or operational updates beyond its routine reporting status.

Why It Matters

This filing indicates Pharvaris N.V. is meeting its ongoing disclosure obligations as a foreign private issuer, which is standard for publicly traded companies.

Risk Assessment

Risk Level: low — This is a routine filing that does not contain new material information or significant financial updates.

Key Players & Entities

• Pharvaris N.V. (company) — Registrant
• Pharvaris, B.V. (company) — Former company name
• 20251112 (date) — Filing date

FAQ

From the Filing

0001193125-25-276005.txt : 20251112 0001193125-25-276005.hdr.sgml : 20251112 20251112080012 ACCESSION NUMBER: 0001193125-25-276005 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20251112 FILED AS OF DATE: 20251112 DATE AS OF CHANGE: 20251112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pharvaris N.V. CENTRAL INDEX KEY: 0001830487 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40010 FILM NUMBER: 251469021 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN PROVINCE COUNTRY: P7 BUSINESS PHONE: 31 (0)71 203 6410 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN PROVINCE COUNTRY: P7 FORMER COMPANY: FORMER CONFORMED NAME: Pharvaris, B.V. DATE OF NAME CHANGE: 20201029 6-K 1 6-k_q3_25.htm 6-K 6-K     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2025 Commission File Number: 001-40010     Pharvaris N.V.   (Translation of registrant’s name into English)   Emmy Noetherweg 2   2333 BK Leiden   The Netherlands (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐ Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐   Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.           PHARVARIS N.V.   On November 12, 2025, Pharvaris N.V. issued a press release reporting financial results and other business updates for the three and nine months ended September 30, 2025. A copy of the press release is attached hereto as Exhibit 99.1 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act. Exhibits 99.2 and 99.3 to this Report on Form 6-K shall be deemed to be incorporated by reference into the registration statements on Form F-3 (Registration Number 333-273757, 333-277705 and 333-278650) and Form S-8 (Registration Number 333-252897) of Pharvaris N.V. and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.           EXHIBIT INDEX &#1